Skip to main content
logo
Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
156.41
+3.14 (2.05%)
Oct 17, 2025, 4:00 PM EDT - Market closed

Revenue by Geography

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2025FY 2025FY 20252012 - 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 2012 - 2021
United States Revenue
220.99B
Log In
Log In
Log In
Upgrade
International Revenue
1.67B
Log In
Log In
Log In
Upgrade
Revenue (Other)
-84.00M
Log In
Log In
Log In
Upgrade
Revenue (Total)
222.58B
Log In
Log In
Log In
Upgrade

Revenue Breakdown

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2025FY 2025FY 20252012 - 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 2012 - 2021
Pharmaceutical and Specialty Solutions Revenue
204.64B
Log In
Log In
Log In
Upgrade
Global Medical Products and Distribution Revenue
12.64B
Log In
Log In
Log In
Upgrade
Other Segment Revenue
5.38B
Log In
Log In
Log In
Upgrade
Revenue (Other)
-84.00M
Log In
Log In
Log In
Upgrade
Revenue (Total)
222.58B
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2025FY 2025FY 20252012 - 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 2012 - 2021
Pharmaceutical Distribution and Specialty Solutions Revenue
-
Log In
Log In
Log In
Upgrade
Nuclear and Precision Health Solutions Revenue
-
Log In
Log In
Log In
Upgrade
Pharmaceutical Segment Revenue
-
Log In
Log In
Log In
Upgrade
Medical Distribution and Products Revenue
-
Log In
Log In
Log In
Upgrade
Cardinal Health at-Home Solutions Revenue
-
Log In
Log In
Log In
Upgrade
Medical Segment Revenue
-
Log In
Log In
Log In
Upgrade
Revenue (Total)
222.58B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2025FY 2025FY 20252012 - 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 2012 - 2021
Pharmaceutical and Specialty Solutions Segment Profit
2.26B
Log In
Log In
Log In
Upgrade
Global Medical Products and Distribution Segment Profit
135.00M
Log In
Log In
Log In
Upgrade
Other Segment Segment Profit
516.00M
Log In
Log In
Log In
Upgrade
Corporate Profit
-634.00M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
2.28B
Log In
Log In
Log In
Upgrade

EBIT 2

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2025FY 2025FY 20252012 - 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 2012 - 2021
Corporate Profit
-634.00M
Log In
Log In
Log In
Upgrade
Pharmaceutical Segment Profit
-
Log In
Log In
Log In
Upgrade
Medical Segment Profit
-
Log In
Log In
Log In
Upgrade
Operating Income (Total)
2.28B
Log In
Log In
Log In
Upgrade
Updated Aug 12, 2025. Data Source: Fiscal.ai.